abrdn plc
Institutional investorEdinburgh
Investment thesis
abrdn is an asset management and investment firm offering a range of strategies for institutional investors and intermediaries, along with investment trusts for individual investors.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 9 of 9 portfolio companiesBiotech ×7Medical Devices ×4Healthtech ×3Digital Health ×2AI & Machine Learning ×1Deep Tech ×1Defense Tech ×1Enterprise Software ×1
HQs:United States×4Canada×1
Investments · 9 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 22024 · 26 dated
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtech
Anthony Fordin
Co-investorsAlta PartnersLongitude CapitalIntermediate Capital GroupJohnson & Johnson Innovation – JJDCNew Leaf Venture PartnersPappas Capital+2 more
Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders.
BiotechDigital HealthMedical DevicesSan Diego, US
Stephen(Co-founder, EVP Research & Development and Chief Development Officer)Paul Cayer(Chief Financial Officer)Vikram(President and Chief Executive Officer)Kimberly(Chief Scientific Officer)Quentin(Chief Technical Officer)
Co-investorsForesite CapitalLongwood FundNorwest Venture PartnersRiverVest Venture PartnersYsios CapitalEight Roads Ventures+4 more
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+8 more
Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development.
BiotechDigital HealthMedical DevicesVancouver, CA
François Bénard(MD)Kuo-Shyan Lin(PhD)David Perrin(PhD)
Co-investorsAndreessen HorowitzDelos CapitalGeneral CatalystLightspeed Venture PartnersLongitude CapitalLumira Ventures+8 more
Atalanta is a mathematical AI company that provides software verification and formal methods capabilities to ensure provably correct decision-making in complex systems for high-stakes missions in energy, space, and defense sectors.
AI & Machine LearningDeep TechDefense Tech
Jonathan Ring(Founder)in
Co-investorsFelicis VenturesEQT Life SciencesF-Prime Capital
Atalanta develops RNA interference-based therapeutics aimed at treating central nervous system and neurological diseases.
BiotechHealthtech
Co-investorsF-Prime CapitalNovartis Venture FundRiverVest Venture PartnersSanofi VenturesEQT Life Sciences
Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.
BiotechMedical DevicesDedham, US
Thurein Htoo(Executive Officer, Director)Fred Guerard(President & Chief Executive Officer)Barbara Wirostko(Executive Officer)
BoardWende Hutton(Director)inRonald M. Hunt(Director)Andrew Danielson(Director)
Co-investorsCanaan PartnersCorrelation VenturesMayo Clinic VenturesNew Leaf Venture Partners
Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering.
BiotechMedical DevicesLower Gwynedd, US
Joseph Erhardt(Executive Officer)Peter Lebowitz(Executive Officer, Director)
BoardArjun Goyal(Director)inOtello Stampacchia(Director)inFrancesco Draetta(Director)in
Co-investorsAndreessen HorowitzVida VenturesBiotechnology Value FundForesite CapitalHillhouse InvestmentOmega Funds+1 more
Titanbay provides a platform for launching and operating private markets fund structures, including Luxembourg vehicles (master, feeder, ELTIF, SMA) and the UK LTAF, with an in-house AIFM.
Enterprise SoftwareFintechSaaS
Co-investorsMotive Partners
Portfolio news
latest coverage across their companies
Abcuro · clinicaltrialsarena.com · Aug 19, 2026
Titanbay · wealthbriefing.com · Aug 13, 2026
Atalanta · castleplacement.com · Jul 9, 2026
Third Arc Bio · allsci.com · Feb 4, 2026
Curasen · nasdaqprivatemarket.com · Mar 2, 2025
Fund performance · per public LP disclosures · 5
as of Jun 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| SL Capital SOF III, L.P.LPs: San Bernardino County Employees Retirement Association | 2017 | — | 18.2% | — | 1.97x |
| SL Capital SOF II, L.P.LPs: San Bernardino County Employees Retirement Association | 2015 | — | 13.9% | — | 1.58x |
| SL Capital SOF I, L.P.LPs: San Bernardino County Employees Retirement Association, Merseyside Pension Fund | 2014 | — | 9.3% | — | 1.36x |
| SL Capital Infrastructure ILPs: West Yorkshire Pension Fund, Merseyside Pension Fund | — | — | — | 1.75x | 0.37x |
| SL Capital Infrastructure IILPs: West Yorkshire Pension Fund, Merseyside Pension Fund | — | — | — | 1.16x | 0.34x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- What sectors does abrdn plc focus on?
- abrdn plc focuses on Crypto & Web3.
- Where is abrdn plc located?
- abrdn plc is headquartered in Edinburgh, GB.
Similar investors
AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
Atomico is an international venture capital firm that invests in growth-stage technology companies across multiple geographies. The firm focuses on scaling disruptive technology businesses globally.
August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.